Thermo Fisher Scientific Inc. (TMO), headquartered in Waltham, Massachusetts, offers life sciences solutions, analytical ...

Thermo Fisher Scientific on Thursday beat Wall Street estimates for fourth-quarter profit and revenue, helped by improved demand for its products and services used in developing therapies. Contract ...

The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.

It's the second time in less than three months that the Waltham-based life sciences firm has announced layoffs.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Thermo Fisher Scientific on Thursday forecast annual profit above Wall Street estimates, banking on improved demand for its products and services used in developing therapies, sending its shares up 6.

Thermo Fisher reported revenue for the quarter grew 5% to $11.40 billion in 2024 versus the same quarter of 2023. Organic revenue growth was 4% and “core” organic revenue growth was 5%.

This was the stock's fifth consecutive day of losses.

Job cuts in Cambridge and Plainville are the second workforce reduction planned for the facilities in the past three months.

Thermo Fisher's unique scale and breadth of products and services have allowed the company to grow market share, and it can continue to do so. This supports the above market long-term growth ...

In a report released today, Daniel Brennan from TD Cowen maintained a Buy rating on Thermo Fisher (TMO – Research Report), with a price target ...

Shares of Thermo Fisher Scientific Inc. TMO slid 1.38% to $545.23 Tuesday, on what proved to be an all-around favorable ...